Search Results 211-220 of 16882 for Brompheniramine

  1. Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Berdazimer (topical application route) - Side effects & dosage - Mayo Clinic

    Berdazimer topical gel is used to treat molluscum contagiosum (molluscum bumps). This medicine is available only with your doctor's prescription. This product ...

  3. An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Diroximel fumarate (oral route) - Side effects & dosage - Mayo Clinic

    Diroximel fumarate is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and ...

  5. Fenoldopam (intravenous route) - Side effects & uses - Mayo Clinic

    Fenoldopam injection is used for in-hospital, short-term (up to 48 hours) management of severe hypertension (high blood pressure) in adults. It is used when ...

  6. Formoterol (inhalation route) - Side effects & dosage - Mayo Clinic

    Formoterol is used together with other medicines (eg, inhaled corticosteroids) to treat asthma and prevent bronchospasm in patients with asthma. When used ...

  7. Ropinirole (oral route) - Side effects & dosage - Mayo Clinic

    Ropinirole is used alone or with other medicines to treat Parkinson's disease. Ropinirole tablets are also used to treat a condition called Restless Legs ...

  8. Prescription Drugs Archives - Mayo Clinic News Network

  9. https://www.mayoclinic.org/spanish_organization_concepts.xml

  10. Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma - Mayo Clinic

    About this study. This is a Phase Ib, open-label, multicenter, global study designed to assess the safety and tolerability of RO6870810 as monotherapy and ...